CANCER CARE BEACON’s Post

🌍💪 European Week Against Cancer 💪🌍. In this European Week Against Cancer, we want to highlight the importance of early detection, efficient treatment and comprehensive support for patients. It is a crucial moment to reflect on the advances and challenges we still face in the fight against this disease. At All.Can Spain, we work tirelessly to identify and alleviate inefficiencies in cancer care. We believe that an efficient, patient-centred healthcare system not only improves clinical outcomes, but also transforms the patient and family experience. Why is our work at All.Can Spain vital? 🌟 Resource Optimisation: We evaluate and propose improvements in resource management to maximise impact. Patient Empowerment: We promote a patient-centred approach, where their needs and voices are heard and valued. Research and Data: We use data and evidence to identify areas for improvement and measure progress. 🤝 We continue to work to ensure that every cancer patient receives the care they deserve, reducing inequalities and improving their quality of life. #EuropeanWeekAgainstCancer #AllCanSpain #FightAgainstCancer 

The new policy brief by the Lung Ambition Alliance Middle East and Africa Chapter uses the Lung Cancer Policy Network's screening implementation framework and applies it to the regional context. Recognising the unique challenges and disparities in lung cancer outcomes across the Middle East and Africa, this effort seeks to create a tailored framework that enhances early detection, reduces lung cancer mortality, and improves patient outcomes. This initiative is a significant step towards transforming lung cancer prevention and management in our region. We call on healthcare professionals, policymakers, and community leaders to join us in this effort. Learn more about our policy brief and how you can get involved 👉 bit.ly/laameachapter #LungCancer #EarlyDetection #LungCancerAwarenessMonth #LungCancerScreening #LAAMEA

💡 Innovation needs to be at the core of cancer care 💡 When we developed #Liberty, we knew innovative thinking was crucial to our mission. Remote cancer care is not just essential for overcoming the many challenges the healthcare system faces, but it's also a powerful way to improve patients’ experiences throughout their treatment journey. It’s encouraging to see the UK Government echo this sentiment in the National Cancer Plan. Layla M. MP, Chair of the Committee, stated: “Our predecessor Committee warned that the current system of cancer care seemed ‘preoccupied with ‘firefighting’ immediate issues’ rather than looking to the future. It called for the redevelopment and publication of a long-term strategy for cancer with innovation at its core.” Although the timeline for the National Cancer Plan is unclear, Entia is ready to drive the adoption of digital solutions like #Liberty, enabling healthcare professionals to deliver proactive, patient-first care. #NHSLongTermPlan #NationalCancerPlan #CancerCare #HealthcareInnovation #Liberty #DigitalHealth #RemotePatientMonitoring #NHS #HospitalAtHome

Debra Montague, Chair of ALK Positive Lung Cancer UK and Vice-president of Lung Cancer Europe, will be speaking at a webinar hosted by the Lung Cancer Policy Network on July 10th. This event is for healthcare professionals, policymakers, patient advocates, and anyone interested in improving lung cancer care. Debra will be discussing how structured care pathways can significantly improve patient experiences, outcomes, and overall health system efficiency. Other key topics include: • Challenges and opportunities across the care pathway • The role of rehabilitation and palliative care • Real-world examples of effective care pathway implementation Find out more and register now → https://lnkd.in/etyShpQe #LungCancerCare #ALKPositive #HealthcarePolicy #LungCancer

There have been many scientific advances in the diagnosis and treatment of lung cancer, yet it is Europe’s leading cause of cancer-related mortality, and so great need remains to accelerate progress for those affected by this disease. Recently we partnered with The Health Policy Partnership to do just that – convening leading lung cancer experts and advocates across Europe to discuss where we can identify opportunities to improve survival. Early detection, targeted innovative treatments and care are key opportunities to improve patient outcomes and survival. By working together with the lung cancer community, we can find solutions that truly make a difference.   Catch up on the conversation below! #LungCancer #InFrontOfCancer #MyCompany

Have you registered for the #AllCanGlobalSummit2024 yet? Our third session will highlight the importance of early detection and care in cancer. In this session, we aim to: ➡ Discuss the challenges and barriers that exist in the current cancer care pathway, particularly related to early detection, and exploring potential solutions ➡ Address disparities in access to cancer care and early detection services and discuss strategies to reduce them ➡ Showcase successful strategies and interventions that have been effective in promoting early detection and efficient cancer care ➡ Highlight ways for measuring impact and efficiency of early detection initiatives and their impact on cancer outcomes, such as survival rates and quality of life.  ➡ Advocate for strengthening the health data ecosystem and the timeliness of care delivery. Event is taking place in a hybrid format on 16 September. Click here to register 👉 https://bit.ly/4cI2rQU

Using data to drive forward changes in cancer services! 💻   The 2024/25 Operational Guidance highlights the crucial need to expand Targeted Lung Health checks (TLC), where all patients with a smoking history are required to be invited for a Lung Health Check by 2029. 🫁   In February 2024, the TU supported West Midlands Cancer Alliance to model current and future capacity across the Lung Cancer Pathway, to support delivery and the aspirations of the TLC programme.   The model developed is adaptable and can be changed depending on a number of different scenarios. This is a great tool to help programmes determine areas of investment or capacity challenges. 💡   As we mark Lung Cancer Awareness Month, this piece of work becomes even more significant/ Early detection through targeted screenings, is critical to improving lung cancer diagnosis and treatment. We can't afford to wait - data driven approaches and investments in lung cancer services are essential to saving lives.   If you want to learn more about how we are shaping the future of lung cancer care through data and innovation, please visit our website https://bit.ly/498Dqxv 🌐   To keep up to date with our work - please follow us!   #HealthcareTransformation #NHSSupport #NHSNewOpportunities #HealthInnovation #NHSTransformation #ChangeManagement #NHSTU #NHS #Diagnostics #CancerPathways #CancerServices #Analytics #Modelling #LungCancerAwarenessMonth 

By 2040, the incidence of new breast cancer cases is predicted to reach more than 3 million per year. Low-income and middle-income countries (LMICs) will be affected the most. 🗺️ The Lancet Commission on Breast Cancer was launched today, highlighting several inequities in breast cancer that are at risk of worsening and can be addressed through global collaboration. Breast cancer is a prioritised cancer across all C/Can cities, and we are working with local stakeholders to improve treatment and speed up diagnosis by ⬇️ ▪️ implementing management guidelines ▪️ refining patient care pathways ▪️ up-skilling healthcare workers ▪️ improving the quality of care processes ▪️ strengtehing system readiness for breast cancer medicines Congratulations to all the authors who contributed to the report, especially Benjamin Anderson, Global Technical Lead for Breast Cancer at City Cancer Challenge, who has been involved in the development and writing of the Commission since its inception in 2020/2021. 👏 🔗https://lnkd.in/dP4Vg5gj #BreastCancer #LMICs #GlobalHealth #HealthEquity #CancerCare

Shifting the Odds Towards Hope with Privado Healthcare At Privado Health, we're not just leading the way in treating prostate cancer with theranostics; we're on a mission to redefine what's possible. According to the National Cancer Institute, an inspiring 97.1% of men diagnosed with prostate cancer will survive for five or more years. We believe in pushing beyond these already hopeful statistics, aiming for a future where every diagnosis is met with a 100% chance of survival. Our dedication to precision medicine and theranostics is at the heart of this mission, offering treatments tailored to each individual's unique cancer. This isn't just about numbers; it's about fathers, brothers, partners, and friends. It's about turning hope into a tangible reality for every person affected by prostate cancer. Join us as we forge ahead, determined to make 100% survival not just a goal, but an expectation. Because at Privado Health, every percentage point is a life that matters. 💙 #PrivadoHealth #ProstateCancerAwareness #TheranosticsInnovation #HopeFor100 #BeatCancerTogether #SurvivalStatistics #PersonalizedMedicine #CancerTreatmentGoals #TogetherWeCan #ProstateCancerSurvival #Theranostics #PersonalizedMedicine #CancerTreatment #InnovativeOncology #PrecisionMedicine #FightCancer #CancerCareRevolution #TargetedTherapy #HealthcareInnovation #CancerAwareness

#BeyondScience To Be #Curable...🎗 🔗 Inspired by Elizabeth Mendes for American Cancer Society: https://lnkd.in/g-PTuVEt 📝 We’ve gathered a few insights on transforming cancer from a fatal disease to a manageable one. Explore our latest carousel to discover the groundbreaking advancements and collaborative efforts needed to make this vision a reality. 🤝Ending cancer requires the collective efforts of scientists, doctors, policymakers, and communities. Explore our carousel to see how we can achieve this together. ✨ Join us in supporting cancer research and innovation. The future is bright, and with your help we can create a future where cancer is no longer a devastating disease. 📌 Follow American Cancer Society and The Babak Lab for the latest developments in cancer treatment and support research initiatives that bring us closer to a cancer-free world. #EndCancer #CancerResearch #HealthcareInnovation #MedicalAdvancements #SupportScience Additional links: Freund, K.M., Battaglia, T.A., Calhoun, E., Dudley, D.J., Fiscella, K., Paskett, E., Raich, P.C., Roetzheim, R.G. and (2008), National Cancer Institute Patient Navigation Research Program† ‡. Cancer, 113: 3391-3399. https://lnkd.in/gpQefCEZ